Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Deloitte
Express Scripts
Federal Trade Commission
Covington
Cantor Fitzgerald

Generated: September 23, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NALTREXONE

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Clinical Trials for NALTREXONE

Trial ID Title Status Sponsor Phase Summary
NCT00000195 Neurobiology of Opioid Dependence: 4 - 4 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on the response to yohimbine in healthy volunteers.
NCT00000195 Neurobiology of Opioid Dependence: 4 - 4 Withdrawn Yale University Phase 2 The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on the response to yohimbine in healthy volunteers.
NCT00000196 Neurobiology of Opioid Dependence: 5 - 5 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.
NCT00000196 Neurobiology of Opioid Dependence: 5 - 5 Withdrawn Yale University Phase 2 The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for NALTREXONE

Condition Name

Condition Name for NALTREXONE
Intervention Trials
Alcoholism 53
Alcohol Dependence 48
Obesity 21
Opioid-Related Disorders 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for NALTREXONE
Intervention Trials
Alcoholism 101
Opioid-Related Disorders 46
Disease 36
Substance-Related Disorders 17
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for NALTREXONE

Trials by Country

Trials by Country for NALTREXONE
Location Trials
United States 668
Germany 13
China 12
Canada 11
Russian Federation 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for NALTREXONE
Location Trials
New York 60
Connecticut 49
Pennsylvania 41
California 41
Texas 35
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for NALTREXONE

Clinical Trial Phase

Clinical Trial Phase for NALTREXONE
Clinical Trial Phase Trials
Phase 4 77
Phase 3 60
Phase 2/Phase 3 24
[disabled in preview] 104
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for NALTREXONE
Clinical Trial Phase Trials
Completed 228
Recruiting 58
Not yet recruiting 25
[disabled in preview] 16
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for NALTREXONE

Sponsor Name

Sponsor Name for NALTREXONE
Sponsor Trials
National Institute on Drug Abuse (NIDA) 79
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 54
Yale University 34
[disabled in preview] 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for NALTREXONE
Sponsor Trials
Other 352
NIH 147
Industry 97
[disabled in preview] 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
McKinsey
Accenture
Chinese Patent Office
QuintilesIMS
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.